Task Force 7: Training in Cardiovascular Research  by Loscalzo, Joseph et al.
APPENDIX 2. PEER REVIEWER RELATIONSHIPS WITH INDUSTRY—ACCF 2008 RECOMMENDATIONS FOR
TRAINING IN ADULT CARDIOVASCULAR MEDICINE CORE CARDIOLOGY TRAINING (COCATS 3)—TASK FORCE 6:
TRAINING IN SPECIALIZED ELECTROPHYSIOLOGY, CARDIAC PACING, AND ARRHYTHMIA MANAGEMENT
Name* Affiliation Consultant
Research
Grant
Scientific
Advisory
Board
Speakers’
Bureau
Steering
Committee
Stock
Holder Other
Dr. Rick A. Nishimura ● Official–Board of Trustees None None None None None None None
Dr. Stuart A. Winston ● Official–Board of
Governors
None None None None None None None
Dr. Anne B. Curtis ● Organizational–Heart
Rhythm Society
● Biosense
● Medtronic
● St. Jude
Medical
● Webster
● Medtronic None ● Boston Scientific
● Medtronic
● St. Jude Medical
None None None
Dr. Dwight W. Reynolds ● Organizational–Heart
Rhythm Society
None None None None None None None
Dr. Peter R. Kowey ● Content–Electrophysiology
Committee
None None None None None None None
Dr. Richard L. Page ● Content–Electrophysiology
Committee
None None None None None None None
Dr. Claudio D. Schuger ● Content–Electrophysiology
Committee
● Stereotaxis ● Guidant
● Medtronic
None None None ● St Jude
Medical
None
This table represents the relationships of peer reviewers with industry that were reported by the authors as relevant to this topic. It does not necessarily reflect relationships with industry at the time of
publication. *Names are listed in alphabetical order with each category of review.
Task Force 7: Training in Cardiovascular Research
Joseph Loscalzo, MD, PHD, FACC, Chair
Gordon F. Tomaselli, MD, FACC, Douglas E. Vaughan, MD, FACC, Richard A. Walsh, MD, FACC
All cardiology training should be performed in institutions in
which the opportunity to participate in research is available.
The training site should be one that will provide an atmosphere
of intellectual inquiry and support of the investigative process.
It is important that every cardiovascular trainee participate
directly in research. Cardiology is a dynamic clinical field in
which the rapid transfer of knowledge from basic and clinical
research to clinical care will continue to occur. This pattern will
only accelerate in the future. Cardiovascular research is defined
in the broadest terms possible because recent history makes it
abundantly clear that advances in the care of patients with
cardiovascular disease have come from diverse areas of medical
science. If the clinical cardiologist is to maintain clinical compe-
tence and improve clinical knowledge in step with the progress of
the field, it is crucial to maintain a thorough understanding of the
concepts, methods, and pitfalls of the research process.
Every trainee should have direct involvement in the practical
aspects of research, with emphasis on learning of how to review
published data, research design, data analysis, and logical
deduction. The research experience plays a unique role in
developing the skills in continuing self-education needed by all
cardiovascular specialists. Trainees contemplating a career in
investigative cardiology bear a special responsibility to prepare
effectively to advance understanding in the broad area of
cardiovascular science and especially the clinical application of
new knowledge.
General Standards
Training Institution
The training institution must have staff and facilities for
research. Opportunities for research for the trainees should
be available not only within the clinical cardiovascular
division but also within the basic biomedical science depart-
ments of the institution. Availability of expertise in epide-
miological methods, outcome evaluation, biostatistics, and
biomedical ethics is essential. Optimally, cardiovascular
training should be performed in a university teaching
hospital or similar institution. Where this is not feasible, an
active ongoing affiliation with a university is essential.
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Preparation
Before their appointment, individual trainees should have
appropriate preparation in the biological, epidemiological,
and physical sciences basic to medicine. If additional course
work is desirable and appropriate, it should be available, and
trainees should be encouraged to avail themselves of it.
Faculty
Faculty of the training program must include several members
with proven skill as investigators, demonstrated by published
original research in peer-reviewed journals. The critical mass of
the faculty requires several cardiovascular investigators, not all
of whom need to be clinical cardiologists. At least 1 full-time
faculty member from each training program should have
demonstrated skill as a clinical investigator.
Content of Training Program
Research “Tracks”
Research training will ordinarily take place in 1 of 3 “tracks”:
Level 1—Trainees entering the clinical practice of car-
diovascular medicine.
Level 2—Trainees planning a commitment to teaching
and clinical investigation.
Level 3—Trainees planning a substantive commitment
to basic or clinically advanced cardiovascular research.
Components of Research
The trainee should develop skills in at least the following areas:
1. literature study, to ascertain the exact state of knowledge
before undertaking new investigation;
2. formulation of hypothesis and specific goals, ensuring that
the hypothesis is testable, that the goals are appropriate,
and that statistical power is achievable;
3. development of the research plan and the protocol, including
study design, importance of appropriate controls in
clinical investigation, and recruitment of subjects, ethi-
cal considerations, informed consent and protection of
privacy, data collection modes, full description of pro-
cedures, and institutional approval of human investiga-
tion, where appropriate, and writing a research grant;
4. data collection, including preparation of routine data forms;
5. development of analytic methods or procedural skills, as
required, and particularly the handling of artifacts,
missing data, outliers, and statistical inference;
6. presentation of results, preferably both oral and written,
emphasizing that no investigation is complete until it is
reported as a full paper in peer-reviewed journals;
7. risk– benefit analysis, regarding both patient (subject) and
societal risk–benefit; and
8. research ethics, recognition of key concepts in the con-
duction of responsible research including but not re-
stricted to data acquisition/management and protection,
conflicts of interest, publication practices, and author-
ship and scientific conduct.
Clinical Investigation
Clinical investigation must be performed under the supervision
of an experienced investigator and according to approved
principles of biomedical ethics and institutional rules for
patient protection. It must be recognized that clinical research
is difficult because of the complexity of achieving valid scientific
conclusions while working with a diverse population and
simultaneously protecting the interests of each patient.
In the case of multicenter clinical trials, participation in
the full range of activities outlined here is required. The
clinician lacking expertise in these areas may be unable to
interpret critical reports that have a direct bearing on his or
her practice. New data may be accepted uncritically or
important advances recognized tardily. The training pro-
gram should provide frequent opportunities for faculty and
trainees to review and analyze small- and large-scale clinical
and basic research reports in depth.
Duration of Research Training
For trainees planning careers in the clinical practice of
cardiovascular medicine (Level 1), 6 to 12 months (and in
many instances up to 18 to 24 months) should be devoted to
a specific project or projects. This research can be under-
taken concurrently with other nonlaboratory clinical train-
ing and may not require a dedicated block of time. For those
planning a substantive commitment to teaching and clinical
investigation (Level 2), a minimum of 18 to 24 months
should be devoted to clinical research. For those planning a
substantive commitment to advanced clinical research
(Level 3), a minimum of 2 full years should be devoted to
mentored clinical research of which at least 1 year could
Summary of Training Requirements for Cardiovascular Research
Table 1 Summary of Training Requirements for Cardiovascular Research
Task
Force Area Level
Minimal Number
of Procedures
Cumulative Duration
of Training (Months)
Minimal Cumulative
Number of Cases Comments
7 Research 1 6 to 12* *Can be taken as part of
9 months of required
nonlaboratory clinical
practice rotation
2 24
3 24 to 36
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occur during fellowship training. Training requirements for
Levels 1, 2, and 3 are summarized in Table 1.
Basic Research
For those planning a career in basic research (Level 3), 2 to
3 full-time years working directly with an experienced
mentor are now needed in most cases. Such training
constitutes only the beginning of the education of an
independent cardiovascular investigator.
Advanced Training for Trainees Considering
Entering Investigative Cardiology
Trainees preparing for careers in research (Level 3) need an
extensive foundation in scientific investigation. Some trainees
will have obtained thorough research preparation in combined
MD/PhD programs, but may lack the specific skills or tools
that are appropriate to their personal research goals. These may
be obtained in a post-doctoral research fellowship experience
or as part of the cardiology traineeship. For full time training,
the trainee should join the group or laboratory of a productive
and active scientist, or clinical investigator (with an MD or
PhD degree), in any qualified institution (not necessarily where
he or she is obtaining direct training).
Trainees who aim for a career in investigative cardiology but
who have not had the opportunity to obtain a PhD degree or
equivalent training at the time they begin their cardiology
traineeships should have the opportunity, and be encouraged,
to obtain the necessary basic scientific analytic course work and
laboratory or clinical research experience necessary for a productive
research career. Currentmodels of this type of training include the
American Heart Association Clinician ScientistAward and the
National Heart, Lung, and Blood Institute program for K08
(Mentored Clinical Scientist Development), K23 (Mentored
Patient-Oriented Research Career Development), or K99/R00
(National Institutes of Health Pathway to Independence)
awards.
Teaching and Manuscript Review
It is important that the trainee be introduced to the basic
principles and skills of education because almost all aca-
demic cardiologists devote a significant amount of time to
teaching. It is highly desirable to provide opportunities for
the critical review and analysis of manuscripts that have
been published or are being considered for publication.
Compensation
Compensation during the often prolonged period of re-
search training should be sufficient to allow a full-time
commitment to this training. Within this context, Congress
recently passed the Clinical Research Enhancement Act,
which mandates debt repayment for MDs or MD/PhDs
engaging in research training.
Evaluation
Evaluation by the Training Director,
Research Sponsor, or Both
Evaluation of a trainee’s progress and skills should be
subjective as well as objective, based on agreed-upon criteria
and standards, and should be ongoing throughout the
training period. The process and documentation currently
required for admittance to the American Board of Internal
Medicine Subspecialty Board Examination serves as a model
for such evaluation. Each trainee’s competence and under-
standing should be documented at the completion of training.
Publication
Trainees should be encouraged to publish substantive results,
thereby providing an evaluation by peer-reviewed journals.
Flexibility
It must be appreciated that the education of future investigative
cardiologists is a continuing process and that they usually
remain in an educational institution where they are immersed
in clinical cardiology. They often have unique demands that
may require altering the sequence and exposure of clinical
training, consistent with their previous clinical experience.
Therefore, the program director should be afforded flexibility
in the assignment of responsibilities for the years of training
while guaranteeing full clinical competence.
Summary
It is vital to the future intellectual health of cardiovascular
medicine and the welfare of patients with cardiovascular
disease that all future cardiologists be familiar with the
principles and tools of research. Training in research re-
quires the intense involvement of productive and established
investigators. Those trainees preparing for a career in
investigative cardiology require a carefully developed but
flexible educational plan that will permit them to be
successful in their research careers over an extended period.
This is a revision of the 2002 document that was written by
Robert Roberts, MD, FACC—Chair; R. Wayne Alexander,
MD, PhD, FACC; Joseph Loscalzo, MD, FACC; and R.
Sanders Williams, MD, FACC.
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Recognition, evaluation, and treatment of heart failure are
essential components of clinical cardiology practice. In order to
achieve competency in this subject, 3 distinct training levels are
defined, with curriculum outlined, in this section (1–4). All
cardiology fellowship training programs will provide, at the
least, a Level 1 curriculum in heart failure. More specifically,
Level 1 training will provide an understanding of the depth and
breadth of the heart failure syndrome, as well as nuances of
therapy including the important topic of heart failure preven-
tion. Level 2 training will be for those individuals who wish to
broaden their experience with heart failure patients, particularly
those with more advanced and challenging syndromes. This
curriculum can, in particular, provide the opportunity to learn
to manage devices (other than circulatory support systems)
implanted for heart failure therapy and arrhythmia or hemo-
dynamic monitoring. Level 2 will also emphasize more detailed
hemodynamic assessment of these patients. Level 3 training
will be for those who anticipate focusing the majority of their
subsequent clinical or research activities on the syndrome of
heart failure with a curriculum requiring an additional 12
months of fellowship training above and beyond that required
for cardiology specialization board examination. It is recog-
nized that not all cardiology fellowship training programs will
be capable of providing the most intense Level 3 training
curriculum. Level 3 training will offer a range of programs that
might, for example, include heart transplantation, mechanical
circulatory support devices, and advanced heart failure electro-
physiology, although not necessarily all of these.
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